Atlas Trials

A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Clinical trial NCT05023915 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05023915
Sponsor
Shandong University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Immune Thrombocytopenia
Start date
2021-08-21
Primary completion
2021-08-21
Enrollment
106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.